Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1405-1409

  Klein, Marina B ^a   Miller, Jeffrey S ^a   Nelson, Curtis M ^a   Goodman, Jesse L ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOPENIA; EHRLICHIOSIS; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION SENSITIVITY; MONOCYTE; PRIORITY JOURNAL;

EID: 0030730254     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517332     Document Type: Article

References (16)

1. Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DU. Human granulocytic ehrlichiosis in the upper Midwest United States. JAMA 1994;272:212-8.
2. Maeda K, Markowitz N, Hawely RC, Ristic M, Cox D, McDade JE. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 1987;316:853-6.
3. Foggie A. Studies on the infectious agent of tick-borne fever in sheep. J Pathol Bacteriol 1951;53:1-15.
4. Rikihisa Y. The tribe Ehrlichiae and ehrlichial diseases. Clin Microbiol Rev 1991;4:286-308.
5. Goodman JL, Nelson C, Vitale B, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996;334:209-15.
6. Bakken JS, Kreuth J, Wilson-Nordskog C, Tilden RL, Asanovitch K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996;275:199-205.
7. Prosper F, Stroncek D, Verfaille CM. Phenotypic and functional characterization of long-term culture initiating cells present in peripheral blood progenitors of normal donors treated with granulocyte-stimulating factor. Blood 1996;88:2033-42.
8. Verfaille CM. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993;82:2045-53.
9. Kaplow LS. Simplified myeloperoxidase staining using benzidine dihydrochloride. Blood 1965;26:215-9.
10. Li CY, Lam K.W, Yam LT. Esterase in human leukocytes. J Histochem Cytochem 1973;21:1-12.
11. Harris P, Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol 1985;37:407-22.
12. Dumler SJ, Sutker WL, Walker DH. Persistent infection with Ehrlichia chaffeensis. Clin Infect Dis 1992;17:903-5.
13. Dumler SJ, Dawson JE, Walker DH. Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis. Hum Pathol 1993;24:391-6.
14. Dinarello CA, Cannon JG, Wolff SM. New concepts in the pathogenesis of fever. Rev Infect Dis 1988;10:168-89.
15. Broxmeyer HE, Williams DE, Lu L, Anderson SL, Beyer GS, Hoffman R, Rubin BY. The suppressive influences of human tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-γ. J Immunol 1986;136:4487-95.
16. Wikel SK. Host immunity to ticks. Annu Rev Entemol 1996;41:1-22.